STIO Life Science.

A PRIVATE JOINT STOCK company established in 2016 FIRST Egyptian Company dedicated to providing “Infection prevention and control company” for healthcare institutions and home providing “Total Solution” to the healthcare sectors and to our community in IPC. 

Shareholder’s structure STIO is a family-owned company with an Authorized Capital of EGP 50 Million and Paid-in Capital EGP 15 Million.